Search

everythinglearnresearchcommunity

for

Search:↓

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Wig users with alopecia do a lot of emotional and practical work to make their wigs look natural and manage how others see them.

The laser comb did not improve hair regrowth in mice with alopecia areata.

JAK inhibitors show promise as a future treatment for hair loss.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Both mouse and rat models are effective for testing alopecia areata treatments.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

Non-immune factors play a significant role in alopecia areata.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.